Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Fluorescent In Situ Hybridization Probe Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The fluorescent in situ hybridization probe market size has experienced robust growth in recent years. It is anticipated to expand from $1.68 billion in 2025 to $1.8 billion in 2026, indicating a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the historic period is largely attributable to the limited availability of fluorescent probes, the reliance on conventional single-color FISH, an increasing awareness of genetic diagnostics, a rise in research funding for molecular biology, and the wider adoption of fluorescence microscopy._x000D_
_x000D_
The market size for fluorescent in situ hybridization probes is projected to experience substantial growth over the coming years. It is forecast to expand to $2.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. The anticipated growth during this period is attributable to the ongoing development of multiplex and combinatorial barcoded probes, an increase in personalized medicine applications, the expansion of pharmaceutical and biotechnology research, a rise in regulatory compliance and standardization, and the integration with AI-driven image analysis and data analytics. Significant trends expected in the forecast period include the rising adoption of FISH probes in clinical diagnostics, the broadening of multiplex and high-throughput screening techniques, their increasing utilization in genetic and agricultural research, integration with advanced imaging and analysis tools, and a dedicated focus on custom probe development for personalized medicine._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Fluorescent In Situ Hybridization Probe Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_
The rising embrace of personalized medicine is projected to fuel expansion within the fluorescent in situ hybridization probe market moving ahead. Personalized medicine denotes a healthcare approach that leverages details regarding an individual’s genetic makeup and lifestyle to customize treatments and care plans specifically for them. This growing acceptance of personalized medicine stems from individuals favoring health technologies that provide real-time monitoring and treatment strategies tailored to their distinct biological characteristics. Fluorescent in situ hybridization (FISH) probes aid personalized medicine by facilitating accurate identification of genetic anomalies at the chromosomal level, which in turn informs bespoke therapeutic choices based on a person’s unique genetic profile. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that the FDA sanctioned 16 new personalized therapies for rare disease patients in 2023, a significant rise from six in 2022. Consequently, the increasing integration of personalized medicine is a key driver for the growth of the fluorescent in situ hybridization probe market._x000D_
_x000D_
#Fluorescent In Situ Hybridization Probe Market Segment Landscape And Growth Outlook#_x000D_
The fluorescent in situ hybridization probe market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes_x000D_
2) By Target: Genes, Chromosomes, Other Targets_x000D_
3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies _x000D_
4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research _x000D_
5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies_x000D_
_x000D_
Subsegments:_x000D_
1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes_x000D_
2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes_x000D_
3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes_x000D_
_x000D_
#Fluorescent In Situ Hybridization Probe Market Strategic Trends: What Defines The Next Growth Phase?#_x000D_
Leading companies within the fluorescent in situ hybridization probe market are increasingly forming strategic alliances to gain entry into novel markets, acquire advanced technologies, or leverage specialized expertise, thereby circumventing the challenges and expenses associated with independent development. A strategic collaboration is defined as a deliberate partnership between multiple entities, wherein they combine their respective strengths and resources to achieve common long-term objectives and reciprocal advantages. An illustrative instance occurred in April 2025, when Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based provider of automated precision dispensing solutions, to introduce the BDot Probe Line. The BDot Probe Line presents a unique offering: FISH probes that are pre-optimized for use with automated systems, thereby resolving a significant hurdle commonly faced in clinical cytogenetics and molecular pathology laboratories. These specific probes are engineered for immediate application, requiring no manual adjustments, which guarantees seamless compatibility and functionality with the Biodot CellWriter S system. This advancement minimizes the necessity for technician involvement, optimizes laboratory workflows, and accelerates the delivery of diagnostic results. The initial collection of BDot Probe Panels facilitates FISH analysis for numerous hematologic malignancies, such as MM, MDS, CML, AML, ALL, along with various other prevalent blood-related disorders._x000D_
_x000D_
#Fluorescent In Situ Hybridization Probe Market Industry Leaders And Competitive Landscape#_x000D_
Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., Cytocell Technologies Limited. _x000D_
_x000D_
#View The Full Fluorescent In Situ Hybridization Probe Market Report:#_x000D_
_x000D_
#Fluorescent In Situ Hybridization Probe Market Regional Analysis And Top Geography#_x000D_
North America was the largest region in the fluorescent in situ hybridization probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
